𝔖 Bobbio Scriptorium
✦   LIBER   ✦

254 cKIT overexpression and wild-type NRAS/BRAF predict response to the tyrosine kinase inhibitor dasatinib in melanoma cell lines

✍ Scribed by F. Journe; M. Wiedig; R. Morandini; F. Sales; G. Ghanem; A. Awada


Book ID
119602936
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
59 KB
Volume
8
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.